AllergyTalk - Episodes by Topic
AllergyTalk Episodes - All Episodes
Click on the CME icon to claim credit for an eligible episode.
- Episode 45 – Should We Wait To Skin Test After A Food Allergy Reaction? (Non-CME)
- Episode 44 – How Does Tryptase Genetics Affect Food Allergy Reactions? (Non-CME)
- Special Episode: Preparing for the Allergy/Immunology Boards
- Episode 43: Does Allergen Immunotherapy Improve Anti-viral Immunity?
- Episode 42: What’s the Best Antibiotic for Kids WIth Sinusitis?
- Episode 41: A Promising New Treatment for SCID
- Episode 40: Intranasal Epinephrine for Anaphylaxis
- AllergyTalk 2-Part Special Episode: Omalizumab for Food Allergy (OUtMATCH) (Non-CME)
- Episode 39: Should We Pay Teenagers to Carry Epinephrine?
- Episode 38: Should Immunotherapy Be Offered For Atopic Dermatitis
- Episode 37: Is There a Role For Allergen Immunotherapy in Seasonal Allergic Asthma? (0:27)
- Episode 36 - How Safe Are Oral Corticosteroids? (0:22)
- Episode 35 - In Kids with Allergic Rhinitis, Remember to Address Sleep Problems? (Non-CME)
- Episode 34 - Are Nasal Polyps An Autoimmune Disease? (Non-CME)
- Episode 33 - Are We Testing for Hymenoptera Backwards? (0:21)
- Episode 32 - How Does the Atopic March Differ in Black and White Children? (0:27)
- Episode 31 - The Presentation of an Inborn Error of Immunity Is Not Always Infection! (0:33)
- Episode 30 - Is COVID Vaccine Skin Testing Useful? (0:30)
- Episode 29 - A New Asthma Biologic, Biomarkers for AERD, mHealth for Asthma (Non-CME)
- Episode 28 - Is IBS a Type of Food Allergy? (Non-CME)
- Episode 27 - How Important is Family History in Infant Peanut Allergy (Non-CME)
- Episode 26 - Does Airborne Peanuts Cause Allergic Reactions? (Non-CME)
- Episode 25 - Is Cefazolin Safe in Penicillin Allergic Patients? (Non-CME)
- Episode 24 - Exercise Should Be Standard Asthma Management
- Episode 23 - Revisiting Acetaminophen and Asthma, Poor Perceivers of Dyspnea
- Episode 22 - Could Anti IL-5 Make Asthma Worse? Egg OIT vs Baked Egg for Egg Allergy
- Episode 21 - T2 Inflammation in CRSsNO; IgG Levels Differ by Gender/Race
- Episode 20 - Methacholine Challenge Caveats; Biologic Super-Responders
- Episode 19 - Using Fractional Exhaled Nitric Oxide to Guide Step-Down Treatment Decisions
- Episode 18 - Asthma Severity and Difficulty Learning to Read
- Episode 17 - Reintroduction Failure After Negative Food ChallengesE
- Episode 16 - Comorbid Laryngeal Dysfunction in Asthma
- Episode 15 - Prenatal Exposure to Air Pollution
- Episode 14 - Food Allergy and Anaphylaxis, plus Success of Peanut OIT
- Episode 13 - Part 2 - Delayed Drug Hypersensitivity
- Episode 13 - Part 1 - Delayed Drug Hypersensitivity
- Episode 12 - Changing Biologics, Mucus Viscosity, Pemphigus and Food Allergy
- Episode 11 - Step Up Therapy in Asthma, A Therapy for Habit Cough
- Episode 10 - OIT Safety, OR Anaphylaxis, and IT for Cats
- Episode 9 - Asthma Epidemiology, Diet, and More on MART Therapy
- Episode 8 -Part 2 - How the College Supports Allergists - Practice Management
- Episode 8 - Part 1 - How the College Supports Allergists - Education and Advocacy
- Episode 7 -Part 2 - An Interview with Brian Vickery
- Episode 7 -Part 1 - An Interview with Brian Vickery
- Episode 6 -Part 2 - Telemedicine in Allergy/Immunology
- Episode 5 - Risk Factors for Venom Allergy, Triggers for Adult-Onset Asthma, and Associations Between Pollution and ED Visits
- Episode 4: Dupliumab for Nasal Polyps and More
- Episode 3: Food Allergy & Eczema
- Episode 2: Asthma
- Episode 1: Pilot
top
The Asthma Urgency Shifting the Rescue Paradigm: A Call-to-Action Miniseries
Asthma exacerbations continue to affect over 40% of asthma patients, which not only disrupts their quality of life but can lead to permanent loss of lung function. The goal of this podcast miniseries is to review why an anti-inflammatory reliever has become the standard of care in asthma management and to provide tips on how to implement this therapy into your practice! Topics include: pathophysiology, exacerbations, anti-inflammatory reliever (AIR), SMART therapy.
- Episode 1: The Limitations of Bronchodilator Only Rescue Therapy (0:14)
- Episode 2: Implementing an Anti-inflammatory Reliever in Mild Asthma (0:19)
- Episode 3: Maintenance and Reliever Therapy in Moderate to Severe Asthma (0:23)
- Expert: William Anderson III, MD, FACAAI
Expert: Alan Baptist, MD, MPH, FACAAI
Expert: Leonard B. Bacharier, MD, FACAAI
Host: Gerald Lee, MD, FACAAI
This podcast series is supported by AstraZeneca.
top
Severe Pediatric Asthma Miniseries
Though severe pediatric asthma only represents from 2 to 5% of the children suffering with this condition, it represents a major share of the cost, resource utilization, and morbidity. It is important that allergists have a good gasp of this condition and how it differs from the adult population.
- Episode 1: Burden of Disease, Adherence Issues, and Comorbidities (0:18)
- Episode 2: Evaluation of the Child, Diagnostic Testing, Assessing Steroid Side Effects (0:22)
- Episode 3: Beyond Standard Therapy, the Role of Current and Future Therapies Including Biologics (0:30)
- Expert: Wanda Phipatanakul, MD, MS, FACAAI
Expert: Pricess Ogbogu, MD, FACAAI
Expert: William Anderson III, MD, FACAAI
Host: Gerald Lee, MD, FACAAI
Explore resources regarding severe pediatric asthma curated by the panel
This podcast series is supported by Sanofi Regeneron.
top
PIDD Disparities Miniseries
Patients with Primary Immunodeficiency Diseases (PIDD) are not only susceptible to infection, but they are also at risk for other, non-infectious, complications. Some of these non-infectious complications can be life-threatening for the patient. This session is intended to discuss how to monitor for these complications, the pathophysiology behind these complications, and the impact new immune therapies have on management of patients with PIDD.
- Episode 1: Underdiagnosis of PIDD in Minority/Underserved Populations (0:14)
- Episode 2: Addressing the Barriers to Diagnosis of PIDD in Minority/Underserved Populations (0:18)
- Episode 3: Improving Access to Treatment for PIDD in Minority/Underserved Populations (0:24)
- Expert: Carla Davis, MD
Expert: Vivan Hernandez-Trujillo, MD
Host: Gerald Lee, MD
Explore PIDD disparities resources selected by the panel
This podcast series is supported by Pfizer.
top
Atopic Dermatitis Disparities Miniseries
Atopic dermatitis is a common disease known to disproportionately impact minorities in a variety of ways. Improving access to care and increasing clinical training can help reduce barriers for underserved populations.
- Episode 1: Current Evidence for Disparities in Atopic Dermatitis (0:19)
- Episode 2: The Influence of Skin of Color in Diagnosing and Managing Patients with Atopic Dermatitis (0:22)
- Episode 3: Improving Access to Treatment for Atopic Dermatitis in Minority and Underserved Populations (0:20)
- Expert: Anil Nanda, MD, FACAAI, FAAAAI, FACP
Expert: Andrew Alexis, MD, MPH
Expert: Marcella Aquino, MD, FACAAI, FAAAAI
Host: Payel Gupta, MD, FACAAI
Explore AD disparities resources selected by the panel
This podcast is supported by an independent medical education grant from Pfizer.
top
Disparities in Chronic Rhinosinusitis with Nasal Polyps Miniseries
CRSwNP has a significant negative impact on patients’ quality of life, affecting work productivity and sleep, and leading to social and emotional consequences, as well increased economic burden. For underserved populations there is a significant impact on morbidity as well. Minority and low-income groups are less likely to receive proper treatment.
- Episode 1: Diagnosis Disparities of Chronic Rhinosinusitis with Nasal Polyps in Minority and Underserved Populations (0:14)
- Episode 2: Impact of Environmental Triggers in CRSwNP for Minority and Underserved Populations (0:13)
- Episode 3: Access to Treatment Disparities for Nasal Polyposis in Minority and Underserved Populations (0:15)
- Expert: Maha Mahdavinia, MD
Expert: Anjeni Keswani, MD
Host: Gerald Lee, MD
Explore CRSwNP disparities resources selected by the panel
This podcast series is supported by Sanofi Regeneron.
top
About AllergyTalk
- AllergyTalk features conversations about the latest research and hot topics in the field of allergy and immunology by the American College of Allergy, Asthma and Immunology. Host Gerald Lee, MD, and AllergyWatch Editor Stanley Fineman, MD, MBA, discuss key articles reviewed in the current issue of AllergyWatch. To listen, search for “AllergyTalk” on iTunes, Google Play, or wherever you listen to podcasts.
- About the Hosts:
Stanley Fineman, MD, MBA, FACAAI is in private practice at Atlanta Allergy & Asthma as well as being an adjunct associate professor of pediatrics in the allergy section at Emory University School of Medicine. He is editor-in-chief of AllergyWatch and a past president of the College. He received the Gold Headed Cane award in 2020.
Gerald B. Lee, MD is an associate professor of pediatrics and internal medicine in the allergy and immunology section at Emory University School of Medicine. He is an assistant editor for AllergyWatch.
top